Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Petitclerc, S. Strömblad, T. Schalscha, F. Mitjans, J. Piulats, A. Montgomery, D. Cheresh, P. Brooks (1999)
Integrin αVβ3 Promotes M21 Melanoma Growth in Human Skin by Regulating Tumor Cell SurvivalCancer Research, 59
M. Stins, F. Gilles, K. Kim (1997)
Selective expression of adhesion molecules on human brain microvascular endothelial cellsJournal of Neuroimmunology, 76
P. Brooks, A. Montgomery, M. Rosenfeld, R. Reisfeld, Tianhua Hu, G. Klier, D. Cheresh (1994)
Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 79
Alf Giesexs, Manfred Westphal (1996)
Glioma invasion in the central nervous system.Neurosurgery, 39 2
S. Chatterjee, A. Matsumura, J. Schradermeier, G. Gillespie (2004)
Human Malignant Glioma Therapy Using Anti-αVβ3 Integrin AgentsJournal of Neuro-Oncology, 46
J. Uhm, C. Gladson, J. Rao (1999)
The role of integrins in the malignant phenotype of gliomas.Frontiers in bioscience : a journal and virtual library, 4
T. Byzova, Ramin Rabbani, Stanley D'Souza, E. Plow (1998)
Role of integrin alpha(v)beta3 in vascular biology.Thrombosis and haemostasis, 80 5
C. Gladson, Josiahn Wilcox, L. Sanders, G. Gillespie, D. Cheresh (1995)
Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors.Journal of cell science, 108 ( Pt 3)
P. Brooks, A. Montgomery, M. Rosenfeld, R. Reisfeld, T. Hu, G. Klier, D. Cheresh (1994)
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.Cell, 79 7
A Korshunov, A Golanov, S Ozerov (1999)
Prognostic value of tumor‐associated antigens immunoreactivity and apoptosis in medulloblastomas. An analysis of 73 cases, 16
C. Gladson, C. Gladson, C. Gladson, D. Cheresh (1991)
Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.The Journal of clinical investigation, 88 6
T. MacDonald, T. Taga, H. Shimada, P. Tabrizi, B. Zlokovic, D. Cheresh, W. Laug (2001)
Preferential Susceptibility of Brain Tumors to the Antiangiogenic Effects of an &agr;v Integrin AntagonistNeurosurgery, 48
F. Mitjans, T. Meyer, C. Fittschen, S. Goodman, A. Jonczyk, J. Marshall, G. Reyes, J. Piulats (2000)
In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.International journal of cancer, 87 5
J. Uhm, N. Dooley, A. Kyritsis, J. Rao, C. Gladson (1999)
Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 6
D. Vitolo, P. Paradiso, S. Uccini, L. Ruco, C. Baroni (1996)
Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: relation to angiogenesis and spreadHistopathology, 28
C. Buckley, D. Pilling, N. Henriquez, Greg Parsonage, K. Threlfall, D. Scheel-Toellner, D. Simmons, A. Akbar, J. Lord, M. Salmon (1999)
RGD peptides induce apoptosis by direct caspase-3 activationNature, 397
E. Petitclerc, S. Strömblad, T. Schalscha, F. Mitjans, J. Piulats, A. Montgomery, D. Cheresh, P. Brooks (1999)
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.Cancer research, 59 11
R. Hynes (1987)
Integrins: A family of cell surface receptorsCell, 48
F. Mitjans, T. Meyer, C. Fittschen, S. Goodman, A. Jonczyk, John Marshall, G. Reyes, J. Piulats (2000)
In vivo therapy of malignant melanoma by means of antagonists of αv integrinsInternational Journal of Cancer, 87
Staffan Strömblad, Jürgen Becker, Mayra Yebra, Peter Brooks, D. Cheresh (1996)
Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis.The Journal of clinical investigation, 98 2
L. Claesson-Welsh, M. Welsh, N. Ito, B. Anand-Apte, S. Soker, B. Zetter, M. O'Reilly, J. Folkman (1998)
Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.Proceedings of the National Academy of Sciences of the United States of America, 95 10
J. Varner, D. Cheresh (1996)
Tumor angiogenesis and the role of vascular cell integrin alphavbeta3.Important advances in oncology
C. Gladson (1996)
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.Journal of neuropathology and experimental neurology, 55 11
P. Brooks, R. Clark, D. Cheresh (1994)
Requirement of vascular integrin alpha v beta 3 for angiogenesis.Science, 264 5158
T. Sethi, R. Rintoul, S. Moore, A. MacKinnon, D. Salter, C. Choo, E. Chilvers, I. Dransfield, S. Donnelly, R. Strieter, C. Haslett (1999)
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivoNature Medicine, 5
P. Carmeliet, R. Jain (2000)
Angiogenesis in cancer and other diseasesNature, 407
S. Chatterjee, A. Matsumura, J. Schradermeier, G. Gillespie (2000)
Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents.Journal of neuro-oncology, 46 2
C. Gladson (1996)
Expression of Integrin avß3 in Small Blood Vessels of Glioblastoma TumorsJournal of Neuropathology and Experimental Neurology, 55
B. Eliceiri, D. Cheresh (1999)
The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.The Journal of clinical investigation, 103 9
Orthotopic brain tumor growth is inhibited in athymic mice by the daily systemic administration of the αv‐integrin antagonist EMD 121974. This compound, a cyclic RGD‐penta‐peptide, is a potent inhibitor of angiogenesis, which induces apoptosis of growing endothelial cells through inhibition of their αv‐integrin interaction with the matrix proteins vitronectin and tenascin. Here we show that EMD 121974 also induces apoptosis in the αv‐integrin‐expressing tumor cell lines U87 MG and DAOY by detaching them from vitronectin and tenascin, matrix proteins known to be essential for brain tumor growth and invasion. These matrix proteins are shown to be produced by the brain tumor cells in vitro and in vivo. Furthermore, only tumor cells expressing αv‐integrins responded to the treatment with EMD 121974, after xenotransplantation into the forebrain of nude mice, supporting the importance of tumor cell‐matrix interactions in tumor cell survival in the brain. Thus, the αv‐antagonist EMD 121974 suppresses brain tumor growth through induction of apoptosis in both brain capillary and brain tumor cells by preventing their interaction with the matrix proteins vitronectin and tenascin. The dual action of this peptide explains its potent growth suppression of orthotopically transplanted brain tumors. © 2002 Wiley‐Liss, Inc.
International Journal of Cancer – Wiley
Published: Jan 10, 2002
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.